login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INCANNEX HEALTHCARE INC (IXHL) Stock News
USA
- NASDAQ:IXHL -
US45333F1093
-
Common Stock
0.38
USD
+0.03 (+9.07%)
Last: 10/20/2025, 9:55:15 PM
0.3821
USD
+0 (+0.55%)
Pre-Market:
10/21/2025, 6:26:58 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IXHL Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Stocktwits
Incannex Healthcare Stock Sees Retail Chatter Explode 234% Over Last Week
a month ago - By: Benzinga
- Mentions:
SNGX
ANTX
CHEK
ADAP
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
2 months ago - By: Benzinga
- Mentions:
BTAI
APP
PLTR
SPY
...
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
2 months ago - By: Stocktwits
This Pharma Stock Soared 23% Today But Is Still Down Over 70% In 2025 – Find Out More
2 months ago - By: Stocktwits
Why Is Incannex Healthcare Stock Surging Today?
2 months ago - By: Incannex Healthcare
Incannex Healthcare Authorizes $20 Million Share Repurchase Program
2 months ago - By: Incannex Healthcare
Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
Please enable JavaScript to continue using this application.